Skip to content

DR. LUC VERWAERDE

Active
Private limited companyfounded 2000active for 26 yearsMolenstede 16, 8300 Knokke-Heist, BelgiumKBO/BCE: BE 0472.414.744

From the official registers: KBO 25 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. LUC VERWAERDE has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €85,621. Equity has been stable since 2019 (±1.6% per year). Its solvency ranks better than 79% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 01-08-2000 Normal situation
Activity
Medical imaging and medical laboratories NACE 86910
Establishment unit
2.228.846.697 8300 Knokke-Heist, since 01-08-2000
Financial year end
30 June
Peppol
Not found in the Peppol Directory

Board and ownership

Board
  • VERWAERDE LUCDirector

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€141,191
▼ 16.9%
Turnover
≈ €280,000
estimated
Profit
€85,621
▼ 36.4%
Equity
€1.1m
▼ 15.4%
Total assets
€1.2m
▼ 10.0%
Staff
1 FTE
=
Filed on 27-01-2026, 4 days before the deadlinePDF
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €1.2mEquity €1.1m (86.8% of total assets)Liquidity: current ratio 8.29, cash €191,519Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 44% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 86.8% of total assets
Liquidity 69-12
short-term debt 11.7% · cash 15.8%
Profitability 78-3
return on assets 7.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024highest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €95,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 8.29 (19.09 in 2024), above the usual 1.5. Short-term debt is 11.7% and cash 15.8% of total assets. 13.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 49% on liquidity, 22% on profitability and 24% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €1.2m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €1.1m (86.8% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 8.29, cash €191,519
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 27-01-2026, 4 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
4 days early
2024
4 days early
2023
8 days late
2022
64 days early
2021
26 days early
2020
1 day early
2019
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 13 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 27 January (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end01-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 94% of companies in human healthsector median €124,628 · 20,680 companies €1.1m View
  • Positive: 7 profitable years in a rowprofit 2025: €85,621 7 years View

Comparable companies

These companies have the same main activity as DR. LUC VERWAERDE: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €711,000 and €1.5m, founded between 1993 and 2003.

CompanyTotal assetsGross margin
DR. LUC VERWAERDE Knokke-Heist€1.2m€0.1m
GASTROLAN Lasne€1.2m€0.2m
HUISARTSENPRAKTIJK RUTSAERT Sint-Niklaas€1.0m€0.2m
DOCTEUR CLAUDE HAUZEUR Mons€0.9m€0.2m
MANUCARE Anhée€0.9m€0.1m
DOKTER VANDAELE MARK Roeselare€1.5m€0.2m
DR. VANNIEUWENBORG - DR. VAN POTTELBERGH Kortrijk€0.7m€0.1m
Full comparison

Documents

Annual accounts at the NBB

All 25 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about DR. LUC VERWAERDE

What is the company number of DR. LUC VERWAERDE?
The company number of DR. LUC VERWAERDE is 0472.414.744. The VAT number is the same number with BE in front: BE 0472.414.744.
Where is DR. LUC VERWAERDE based?
The registered office is at Molenstede 16, 8300 Knokke-Heist.Company details
What does DR. LUC VERWAERDE do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of DR. LUC VERWAERDE?
The legal form of DR. LUC VERWAERDE is Private limited company (BV).
When was DR. LUC VERWAERDE founded?
DR. LUC VERWAERDE was founded on 01-08-2000.
Is DR. LUC VERWAERDE still active?
Yes, DR. LUC VERWAERDE is an active enterprise in the KBO register.
How many employees does DR. LUC VERWAERDE have?
DR. LUC VERWAERDE had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DR. LUC VERWAERDE?
The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €141,191 and 82 comparable companies (NACE 86). It probably lies between €210,000 and €350,000.
Is DR. LUC VERWAERDE profitable?
In financial year 2025, DR. LUC VERWAERDE made a profit of €85,621.
Where can I find the annual accounts of DR. LUC VERWAERDE?
DR. LUC VERWAERDE filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of DR. LUC VERWAERDE due?
DR. LUC VERWAERDE must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.